DOI QR코드

DOI QR Code

Complications of Cardiac Catheterization in Structural Heart Disease

  • Lee, Ko Eun (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Seo, Yeon Jeong (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Kim, Gi Beom (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • An, Hyo Soon (Department of Pediatrics, Seoul National University Boramae Hospital) ;
  • Song, Young Hwan (Department of Pediatrics, Bundang Seoul National University Hospital) ;
  • Kwon, Bo Sang (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Bae, Eun Jung (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Noh, Chung Il (Department of Pediatrics, Seoul National University Children's Hospital)
  • Received : 2015.07.13
  • Accepted : 2015.09.22
  • Published : 2016.03.30

Abstract

Background and Objectives: Cardiac catheterization is used to diagnose structural heart disease (SHD) and perform transcatheter treatment. This study aimed to evaluate complications of cardiac catheterization and the associated risk factors in a tertiary center over 10 years. Subjects and Methods: Total 2071 cardiac catheterizations performed at the Seoul National University Children's Hospital from January 2004 to December 2013 were included in this retrospective study. Results: The overall complication, severe complication, and mortality rates were 16.2%, 1.15%, and 0.19%, respectively. The factors that significantly increased the risk of overall and severe complications were anticoagulant use before procedure (odds ratio [OR] 1.83, p=0.012 and OR 6.45, p<0.001, respectively), prothrombin time (OR 2.30, p<0.001 and OR 5.99, p<0.001, respectively), general anesthesia use during procedure (OR 1.84, p=0.014 and OR 5.31, p=0.015, respectively), and total procedure time (OR 1.01, p<0.001 and OR 1.02, p<0.001, respectively). Low body weight (OR 0.99, p=0.003), severe SHD (OR 1.37, p=0.012), repetitive procedures (OR 1.7, p=0.009), and total fluoroscopy time (OR 1.01, p=0.005) significantly increased the overall complication risk. High activated partial thromboplastin time (OR 1.04, p=0.001), intensive care unit admission state (OR 14.03, p<0.001), and concomitant electrophysiological study during procedure (OR 3.41, p=0.016) significantly increased severe complication risk. Conclusion: Currently, the use of cardiac catheterization in SHD is increasing and becoming more complex; this could cause complications despite the preventive efforts. Careful patient selection for therapeutic catheterization and improved technique and management during the peri-procedural period are required to reduce complications.

Keywords

References

  1. Kim GB. Psychosocial adjustment and quality of life of adolescents and adults with congenital heart disease. Korean J Pediatr 2014;57:257-63. https://doi.org/10.3345/kjp.2014.57.6.257
  2. Mehta R, Lee KJ, Chaturvedi R, Benson L. Complications of pediatric cardiac catheterization: a review in the current era. Catheter Cardiovasc Interv 2008;72:278-85. https://doi.org/10.1002/ccd.21580
  3. Porter CJ, Gillette PC, Mullins CE, McNamara DG. Cardiac catheterization in the neonate. A comparison of three techniques. J Pediatr 1978;93:97-101. https://doi.org/10.1016/S0022-3476(78)80614-3
  4. Booth P, Redington AN, Shinebourne EA, Rigby ML. Early complications of interventional balloon catheterisation in infants and children. Br Heart J 1991;65:109-12. https://doi.org/10.1136/hrt.65.2.109
  5. Cassidy SC, Schmidt KG, Van Hare GF, Stanger P, Teitel DF. Complications of pediatric cardiac catheterization: a 3-year study. J Am Coll Cardiol 1992;19:1285-93. https://doi.org/10.1016/0735-1097(92)90336-L
  6. Yetman AT, Nykanen D, McCrindle BW, et al. Balloon angioplasty of recurrent coarctation: a 12-year review. J Am Coll Cardiol 1997;30:811-6. https://doi.org/10.1016/S0735-1097(97)00228-3
  7. Zeevi B, Berant M, Fogelman R, Galit BM, Blieden LC. Acute complications in the current era of therapeutic cardiac catheterization for congenital heart disease. Cardiol Young 1999;9:266-72.
  8. Rhodes JF, Asnes JD, Blaufox AD, Sommer RJ. Impact of low body weight on frequency of pediatric cardiac catheterization complications. Am J Cardiol 2000;86:1275-8, A9. https://doi.org/10.1016/S0002-9149(00)01221-2
  9. Mori Y, Nakazawa M, Yagihara T. Complications of pediatric cardiac catheterization and system of catheterization laboratories minimizing complications--a Japanese multicenter survey. J Cardiol 2010;56:183-8. https://doi.org/10.1016/j.jjcc.2010.05.001
  10. West R, Ellis G, Brooks N; Joint Audit Committee of the British Cardiac Society and Royal College of Physicians of Londo. Complications of diagnostic cardiac catheterisation: results from a confidential inquiry into cardiac catheter complications. Heart 2006;92:810-4.
  11. Warnes CA, Liberthson R, Danielson GK, et al. Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol 2001;37:1170-5. https://doi.org/10.1016/S0735-1097(01)01272-4
  12. Vitiello R, McCrindle BW, Nykanen D, Freedom RM, Benson LN. Complications associated with pediatric cardiac catheterization. J Am Coll Cardiol 1998;32:1433-40. https://doi.org/10.1016/S0735-1097(98)00396-9
  13. Brotschi B, Hug MI, Kretschmar O, Rizzi M, Albisetti M. Incidence and predictors of cardiac catheterisation-related arterial thrombosis in children. Heart 2015;101:948-53. https://doi.org/10.1136/heartjnl-2014-306713
  14. Krasemann T. Complications of cardiac catheterisation in children. Heart 2015;101:915. https://doi.org/10.1136/heartjnl-2015-307453
  15. Luceri MJ, Tala JA, Weismann CG, Silva CT, Faustino EV. Prevalence of post-thrombotic syndrome after cardiac catheterization. Pediatr Blood Cancer 2015;62:1222-7. https://doi.org/10.1002/pbc.25438
  16. Lin CH, Desai S, Nicolas R, et al. Sedation and anesthesia in pediatric and congenital cardiac catheterization: a prospective multicenter experience. Pediatr Cardiol 2015;36:1363-75. https://doi.org/10.1007/s00246-015-1167-8
  17. Bobhate P, Guo L, Jain S, et al. Cardiac catheterization in children with pulmonary hypertensive vascular disease. Pediatr Cardiol 2015;36:873-9. https://doi.org/10.1007/s00246-015-1100-1
  18. Busing KA, Schulte-Sasse C, Fluchter S, et al. Cerebral infarction: incidence and risk factors after diagnostic and interventional cardiac catheterization--prospective evaluation at diffusion-weighted MR imaging. Radiology 2005;235:177-83. https://doi.org/10.1148/radiol.2351040117
  19. De Bono D. Complications of diagnostic cardiac catheterisation: results from 34,041 patients in the United Kingdom confidential enquiry into cardiac catheter complications. The Joint Audit Committee of the British Cardiac Society and Royal College of Physicians of London. Br Heart J 1993;70:297-300. https://doi.org/10.1136/hrt.70.3.297
  20. Glatz AC, Shah SS, McCarthy AL, et al. Prevalence of and risk factors for acute occlusive arterial injury following pediatric cardiac catheterization: a large single-center cohort study. Catheter Cardiovasc Interv 2013;82:454-62. https://doi.org/10.1002/ccd.24737
  21. Stone PA, Campbell JE, AbuRahma AF. Femoral pseudoaneurysms after percutaneous access. J Vasc Surg 2014;60:1359-66. https://doi.org/10.1016/j.jvs.2014.07.035
  22. Zuckerman WA, Turner ME, Kerstein J, et al. Safety of cardiac catheterization at a center specializing in the care of patients with pulmonary arterial hypertension. Pulm Circ 2013;3:831-9. https://doi.org/10.1086/674752

Cited by

  1. Complications during catheter‐mediated patent ductus arteriosus closure and pulmonary balloon valvuloplasty vol.60, pp.10, 2016, https://doi.org/10.1111/jsap.13046